Sargent Bickham Lagudis’s Biogen BIIB Stock Holding History

Sargent Bickham Lagudis’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$3.05K	Sell	11 -20	-65%	-$5.65K	﹤0.01%	860
2022 Q3	$8K	Hold	31	–	–	﹤0.01%	716
2022 Q2	$6K	Hold	31	–	–	﹤0.01%	758
2022 Q1	$6K	Hold	31	–	–	﹤0.01%	767
2021 Q4	$7K	Hold	31	–	–	﹤0.01%	753
2021 Q3	$9K	Hold	31	–	–	﹤0.01%	729
2021 Q2	$11K	Sell	31 -5	-14%	-$1.51K	﹤0.01%	696
2021 Q1	$10K	Buy	36 +5	+16%	+$1.35K	﹤0.01%	687
2020 Q4	$8K	Buy	31 +20	+182%	+$5.16K	﹤0.01%	685
2020 Q3	$3K	Hold	11	–	–	﹤0.01%	695
2020 Q2	$3K	Hold	11	–	–	﹤0.01%	676
2020 Q1	$3K	Hold	11	–	–	﹤0.01%	669
2019 Q4	$3K	Hold	11	–	–	﹤0.01%	731
2019 Q3	$3K	Hold	11	–	–	﹤0.01%	654
2019 Q2	$3K	Hold	11	–	–	﹤0.01%	689
2019 Q1	$3K	Hold	11	–	–	﹤0.01%	723
2018 Q4	$3K	Sell	11 -16	-59%	-$5.11K	﹤0.01%	695
2018 Q3	$10K	Buy	27 +16	+145%	+$5.51K	﹤0.01%	604
2018 Q2	$3K	Sell	11 -10	-48%	-$2.81K	﹤0.01%	697
2018 Q1	$6K	Hold	21	–	–	﹤0.01%	643
2017 Q4	$7K	Hold	21	–	–	﹤0.01%	645
2017 Q3	$7K	Hold	21	–	–	﹤0.01%	658
2017 Q2	$6K	Buy	21 +10	+91%	+$2.64K	﹤0.01%	632
2017 Q1	$3K	Hold	11	–	–	﹤0.01%	678
2016 Q4	$3K	Buy	+11	New	+$3.26K	﹤0.01%	650
2016 Q3	–	Sell	-9,576	Closed	-$2.32M	–	728
2016 Q2	$2.32M	Sell	9,576 -1,106	-10%	-$291K	0.36%	80
2016 Q1	$2.78M	Buy	+10,682	New	+$2.82M	0.45%	65

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Sargent Bickham Lagudis's BIIB Position: Q4 2022 in Review

Sargent Bickham Lagudis reduced its Biogen (BIIB) stake by 65% in Q4 2022, selling an estimated $5.65K and leaving 11 shares worth $3.05K. The position accounts for ﹤0.01% of the portfolio, ranked #860.

Sargent Bickham Lagudis first reported a position in BIIB in Q1 2016 and has held it in 27 quarters since. The position peaked at $2.78M in Q1 2016. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

Sargent Bickham Lagudis held 11 shares of Biogen worth $3.05K as of Q4 2022.
Sargent Bickham Lagudis sold 20 Biogen shares in Q4 2022, an estimated $5.65K.
Biogen made up ﹤0.01% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #860 holding.
Sargent Bickham Lagudis first reported a position in Biogen in Q1 2016 and has held it in 27 quarters since.
Sargent Bickham Lagudis's Biogen position peaked at $2.78M in Q1 2016.
1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.